Updating {{drugbox}} (no changed fields - added verified revid - updated 'UNII_Ref', 'ChEMBL_Ref') per Chem/Drugbox validation (report errors or [[user
|
No edit summary
|
||
Line 1: | Line 1: | ||
{{ |
{{drugbox |
||
| UNII_Ref = {{fdacite|correct|FDA}} |
|||
| UNII = 195V08O55G |
|||
| verifiedrevid = 410152515 |
| verifiedrevid = 410152515 |
||
|IUPAC_name = |
|IUPAC_name = |
![]() | |
Identifiers | |
---|---|
PubChem CID | |
ChemSpider |
|
UNII | |
KEGG |
|
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C8H10ClN3S |
Molar mass | 215.70 g/mol g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
Tiamenidine is a compound that shares a lot of the pharmacological properties of clonidine.
Rippel, H.; Ruschig, H.; Linder, E.; Schorr, M.; 1973, U.S. patent 3,758,476.
| |
---|---|
CNSTooltip central nervous system stimulants |
|
Non-classical CNS stimulants |
|
α2-adrenoceptor agonists |
|
Antidepressants |
|
Miscellaneous/others |
|
Related articles |
|
| |||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sympatholytics (antagonize α-adrenergic vasoconstriction) |
| ||||||||||||||||||||||||||
Other antagonists |
| ||||||||||||||||||||||||||
|